MSB 8.42% $1.03 mesoblast limited

If it fails to get up, most likely on the basis of production...

  1. 15,591 Posts.
    lightbulb Created with Sketch. 5654
    If it fails to get up, most likely on the basis of production concerns, then it's going to be very difficult for the subsequent products to also get up

    Yes of course, if Remestemcel-L is overwhelmingly successful in the COVID-19 space I can see them just tossing it aside because Ryoncil was rejected .... NIH would have just poured $50m USD down the drain as well ... lol
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
0.080(8.42%)
Mkt cap ! $1.124B
Open High Low Value Volume
95.5¢ $1.03 95.0¢ $34.85M 34.00M

Buyers (Bids)

No. Vol. Price($)
4 72752 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.03 205100 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.